Our client, a global consumer goods company, wished to expand into a foreign market where consumers favoured different medical devices. They had identified a manufacturer for white label operation under their established brand and wished to assess the occurrence of adverse events in the potential asset.
Our client wished to extend their rigorous pharmacovigilance standards to any potential assets to determine how advantageous the commercial opportunity may be. They required an assessment of product quality unbiased from the reports given by the manufacturer.
To establish a comprehensive scientific landscape analysis, we delivered an extensive statistical analysis and payer review report to support the client in deciding if they should proceed.
- We web scraped manufacturer and competitor reviews of multiple sexual health consumer products from foreign e-commerce websites
- A robust comparative statistical analysis study benchmarked against known market-leading brands to observe relevant trends and make recommendations to our client
- Known concerns and unknown potential issues were identified through natural language processing and a sentiment analysis of the payer reviews was conducted
The value to the client
Providing a rapid and thorough analysis to the client, backed by real world evidence allowing them to make an informed, unbiased decision on the use of the chosen manufacturer which may lead to future manufacturer acquisition.